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Since their discovery in 1879, basophils have been
viewed as circulating blood granulocytes with limited
immune function. New research tools for their func-
tional analysis in vivo have revealed previously
unrecognized roles for basophils in several skin dis-
orders. Human basophils infiltrate different skin
lesions and have been implicated in the pathogenesis
of diseases ranging from chronic idiopathic urticaria to
systemic lupus erythematosus. In mouse models, baso-
phils participate in IgE–mediated chronic allergic inflam-
mation of the skin and have a protective role in tick
infestation. In this review, we discuss critical advances
in our understanding of basophil biology and their
roles in the pathophysiology of skin disorders.
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INTRODUCTION
Basophils are circulating granulocytes that account for
o1% of blood leukocytes. They were discovered by Ehrlich in
1879 because of the affinity of their cytoplasmic granules
for basic dyes (Ehrlich, 1879). Since then, basophils have
been a challenge for immunologists owing to their rarity
and to the relative lack of specific experimental tools and
animal models (Marone et al., 2014, in press). Basophils
have often been mistakenly considered surrogates or even
blood-circulating precursors of tissue-resident mast cells.
In the early 1970s, it was discovered that IgE molecules
bind with high affinity to human basophils and that cross-
linking of the high-affinity IgE receptor (FceRI) with antigens
or anti-IgE induces histamine release (Ishizaka et al., 1970,
1972). At that time, basophils were extensively studied in the
context of a delayed-onset cutaneous hypersensitivity,
designated ‘‘Jones–Mote hypersensitivity’’ in humans and
‘‘cutaneous basophil hypersensitivity’’ in guinea pigs
(Katz, 1978). The evidence that basophil depletion did not
modify cutaneous basophil hypersensitivity, together with the
mistaken belief that mice lack basophils, tempered the interest
of skin immunologists for basophil biology (Galli et al., 1978;
Urbina et al., 1981). Nevertheless, mouse basophils were
characterized in 1982 (Dvorak et al., 1982).
The 1990s were marked by the seminal observation that
human and mouse basophils produce the T helper 2 (Th2)–
type cytokines IL-4 and IL-13 (Piccinni et al., 1991; Seder
et al., 1991; Brunner et al., 1993; MacGlashan et al., 1994;
Schroeder et al., 1994; Gibbs et al., 1996; Li et al., 1996;
Ochensberger et al., 1996; Redrup et al., 1998). These in vitro
findings implicated basophils in the pathophysiology of
Th2-type immune responses, namely allergic disorders and
immune response to parasitic infections. In 2004, two strains
of IL-4/green fluorescent protein reporter mice, namely 4get
(Voehringer et al., 2004) and G4 (Min et al., 2004), were
generated, allowing the identification of basophils as a source
of IL-4 during immune responses. Only recently have the
distinct roles played by basophils and mast cells in innate and
adaptive immunity been assessed in vivo (Obata et al., 2007;
Sokol et al., 2009; Ohnmacht et al., 2010; Wada et al., 2010;
Karasuyama et al., 2011; Sullivan et al., 2011; Sawaguchi
et al., 2012).
Although the physiological role of basophils remains enig-
matic, basophils were reported to mediate nonredundant roles
in the pathogenesis of specific types of allergic inflammation
in the skin (Mukai et al., 2005; Obata et al., 2007; Ohnmacht
et al., 2010; Sawaguchi et al., 2012) and in the development
of acquired resistance toward tick infestation (Wada et al.,
2010). Basophil recruitment to skin lesions has also been
observed in several human diseases (Dvorak and Mihm, 1972;
Ying et al., 2002; Ito et al., 2011).
This review focuses on the roles of basophils in the
pathophysiology of skin disorders in the light of recent
advances in the biology of human and mouse basophils and
the new tools for assessing their functions in vivo. Never-
theless, caution should be exercised in extrapolating findings
obtained in mouse models to humans because of species-
related differences and technical difficulties in identifying
mouse basophils (Lee and McGarry, 2007). Mouse basophils
differ from basophils of other species in terms of morphology
and staining features. Specifically, compared with human
basophils (Urbina et al., 1981), they have fewer granules,
which moreover are of different sizes. Therefore, the
identification of mouse basophils by conventional staining
protocols (e.g., May-Giemsa) may be cumbersome. On the
other hand, over-reliance on cell-surface markers alone may
lead to a poor characterization of this leukocyte population.
Thus, the identity of basophils in experimental mouse models
should be assessed by carefully evaluating their phenotypic,
functional, and morphological features in order to verify the
relevance of these models to humans.
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GENERAL ASPECTS OF HUMAN AND MOUSE BASOPHIL
BIOLOGY
Basophils develop in the bone marrow from basophil pre-
cursors and enter the circulation with a fully mature pheno-
type (Iwasaki and Akashi, 2007), although an exception to this
rule has been reported (Saenz et al., 2010). Mature basophils
are relatively short-lived (E60 hours in mice). Being termi-
nally differentiated cells, basophils do not proliferate (Iwasaki
and Akashi, 2007; Ohnmacht and Voehringer, 2009). Thus, a
constant pool of circulating basophil relies on continuous cell
differentiation from basophil precursors. This process depends
on the timing of the expression of transcription factors (Iwasaki
and Akashi, 2007) and on the action of IL-3 and/or thymic
stromal lymphopoietin (TSLP) (Dvorak et al., 1989a,b;
Lantz et al., 1998; Ohmori et al., 2009; Siracusa et al.,
2011; Giacomin et al., 2012). However, neither of these
cytokines is required for basophil differentiation at steady
state, suggesting the involvement of other as yet unknown
factors (Voehringer, 2013). It is important to stress that most of
what we know about basophil development derives from
mouse models and may not reflect what happens in humans.
Basophils express a complete form (abg2) of FceRI and
rapidly release a variety of preformed (histamine, basogranu-
lin, vascular endothelial growth factor (VEGF), etc.) and
de novo–synthesized (LTC4, chemokines/cytokines, etc.) medi-
ators in response to IgE cross-linking (antigens, superantigens,
anti-IgE) or to IgE-independent stimuli (e.g., cytokines, anti-
IgD, anaphylatoxins, proteases, TLR ligands, etc.) (Marone,
2007; Chen et al., 2009; Voehringer, 2013).
Human and mouse basophils express the IL-3 receptor
a-chain (CD123). IL-3 is released by activated T cells, mast
cells (Cockerill, 2004), or basophils themselves (Schroeder
et al., 2009), thus acting also in an autocrine manner. IL-3 is
the most potent basophil-activating cytokine and promotes
basophil differentiation (Voehringer, 2012). In its absence,
TSLP gives rise to a population of mouse basophils pheno-
typically and functionally distinct from IL-3-elicited basophils.
TSLP-elicited basophils produce more cytokines and chemo-
kines in response to IL-3, IL-33, and IL-18 compared with
IL-3-elicited basophils, which in turn are more prone to
degranulate in response to IgE cross-linking (Siracusa et al.,
2011, 2012). It remains to be established whether TSLP- and
IL-3-elicited basophils are distinct cell subsets or just different
states of activation. Furthermore, it is unclear to what extent
this model can be translated to human basophils.
The production of Th2-type cytokines (IL-4 and IL-13) is a
well-recognized hallmark of both human and mouse baso-
phils, whereas the expression of other cytokines by human
basophils (e.g., IL-5, IL-6, tumor necrosis factor-a and TSLP)
remains to be unequivocally established (Denzel et al., 2008;
Smithgall et al., 2008; Sokol et al., 2008; Schroeder, 2011;
Falkencrone et al., 2013). Several reasons could account for
these discrepancies, namely the source of the cells (tissue-
and/or lymph node–derived basophils versus circulating
basophils), contamination with monocytes or dendritic cells
(DCs), or species-related differences.
Are mouse and human basophils antigen-presenting cells
(APCs)? Three groups reported that mouse basophils function
as APCs and are sufficient for Th2 differentiation in vitro and
in vivo in response to the cysteine protease papain (Sokol
et al., 2009), helminth infection (Perrigoue et al., 2009), and
ovalbumin (OVA) (Yoshimoto et al., 2009). However, these
results were obtained using MAR-1, a depleting antibody
specific for FceRI that may deplete not only basophils but
also FceRIþ mast cells and DCs. Subsequent assessment of the
relative contribution of DCs and basophils to induction of Th2
responses showed that basophils were either dispensable
(Hammad et al., 2010; Phythian-Adams et al., 2010) or at
best cooperated with DCs to induce an optimal Th2 response
(Tang et al., 2010). These results were confirmed in transgenic
mice in which basophils were either constitutively deficient
(Ohnmacht et al., 2010; Sullivan et al., 2011) or depleted by
diphtheria toxin (DT) administration (Wada et al., 2010;
Sawaguchi et al., 2012). Intriguingly, mouse basophils are
required to induce Th2 immunity after repeated skin
application of haptens or intraperitoneal injections of an
OVA peptide but not of intact OVA, because they do not
process protein antigens (Otsuka et al., 2013a). Nonetheless,
basophils isolated from peripheral blood of healthy subjects
or allergic patients do not behave as APCs for allergens
(Eckl-Dorna et al., 2012; Kitzmuller et al., 2012; Sharma
et al., 2013). Overall, the experimental data obtained in
mouse models or in humans tend to exclude the fact that
basophils are professional APCs. Nevertheless, the contri-
bution of these cells and their mediators to the polarization
of Th2 lymphocytes and M2 monocytes/macrophages (Anthony
et al., 2011; Egawa et al., 2013) warrants additional
investigation.
NEW TOOLS FOR THE STUDY OF HUMAN AND MOUSE
BASOPHILS
Basophil biology is becoming clearer owing to new tools that
have enabled more specific phenotype profiling and in-depth
functional analyses in vitro and in vivo (see Table 1).
Human basophils can be identified by flow cytometry using
combinations of surface markers (FSclo, SSclo, FceRIþ ,
CD203cþ , CD117 , etc.). However, they are easily distin-
guishable among peripheral blood cells as CD123þ BDCA-
2 cells. The latter is a specific marker of plasmacytoid DCs
that also express high CD123 levels (Frischmeyer-Guerrerio
and Schroeder, 2012). Human basophils can be detected in
histological specimens using monoclonal antibodies that
recognize basogranulin (BB1) (McEuen et al., 1999), a
cytoplasmic protein (2D7) (Kepley et al., 1995), or pro-major
basic protein 1 (J175-7D4) (Plager et al., 2006). The degranu-
lation status of human basophils can be assessed by flow
cytometry using monoclonal antibodies against CD63 and
CD203c (McGowan and Saini, 2013). Upregulation of CD63
is considered a marker of anaphylactic degranulation (rapid
morphological changes and exocytosis of intracellular
granules) (Knol et al., 1991; MacGlashan, 2010), whereas
CD203c upregulation may be associated with piecemeal
degranulation (granule content secretion without exocytosis)
(Bu¨hring et al., 2004; MacGlashan, 2012). Several novel
basophil activation markers have been suggested (phospho-
p38 (Ebo et al., 2007), CD13, CD107a, CD164 (Hennersdorf
F Borriello et al.
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et al., 2005)), but their clinical usefulness requires further
evaluation.
Mouse basophils express a pattern of surface markers
consistent with human basophils and can be recognized
by flow cytometry as FSclo, SSclo, FceRIþ , CD49bþ , CD69þ ,
Thy-1.2þ , CD123þ , CD200Rþ , CD117 , CD19 , CD14 ,
CD122 , CD11c , Gr-1 , NK1.1 , B220 , CD3 ,
abTCR , and gdTCR cells (Siracusa et al., 2012). In addi-
tion, a monoclonal antibody directed against mouse mast cell
protease 8 (mMCP-8), which is a basophil-specific granzyme
B–like protease, can be used to verify the identity of mouse
basophils and detect them in histological sections (Ugajin et al.,
2009). To gain insight into basophil functions in vivo, several
groups used two monoclonal antibodies (MAR-1 (Sokol et al.,
2008) and Ba103 (Obata et al., 2007), respectively specific for
FceRIa and CD200R3) that transiently deplete basophils in
mice. However, these antibodies activate and/or induce partial
depletion of FceRIþ mast cell and DCs (Hammad et al., 2010;
Phythian-Adams et al., 2010). Therefore, inducible or constitu-
tive basophil-deficient mouse strains based on a basophil-
specific differentiation marker (mMCP-8) (Ohnmacht et al.,
2010; Wada et al., 2010; Sullivan et al., 2011) or basophil-
specific Il4 enhancer elements (Sawaguchi et al., 2012) have
been established so that the roles of basophils can be evaluated
distinct from those of mast cells.
BASOPHILS IN MOUSE MODELS OF SKIN DISORDERS
The first clear evidence that mouse basophils have a funda-
mental role in skin allergic inflammation was reported by
the group of Karasuyama (Mukai et al., 2005) (see Table 2).
They developed a model of IgE-mediated chronic allergic
inflammation (IgE-CAI), consisting in a single subcutaneous
injection of antigen in the ear of mice passively sensitized with
antigen-specific IgE. After antigen injection, three consecutive
waves of ear swelling are observed: the first (E1 hour post
injection), the second (within 6–10 hours), and the third wave,
named ‘‘IgE-CAI’’ (starting on day 2 with a peak on day 4 post-
antigen challenge), which is characterized by massive
infiltration of eosinophils, monocytes/macrophages, and by
hyperplastic epidermis with hyperkeratosis. Interestingly, mast
cell depletion abolished the first two waves of ear swelling
but not IgE-CAI, whereas FceRI-deficient mice were resistant
Table 1. Tools for the study of human and mouse basophils
mAb—mouse strain
denomination mAb molecular target—mouse strain phenotype Experimental use and functional readouts References
Human basophils
BB1 mAb specific for basogranulin Detection of human basophils in histological specimens McEuen et al.,
1999
2D7 mAb specific for a yet unidentified cytoplasmic
protein
Detection of human basophils in histological specimens Kepley et al., 1995
J175-7D4 mAb specific for pro-major basic protein 1 Detection of human basophils in histological specimens Plager et al., 2006
Anti-CD63 mAb mAb specific for a lysosomal glycoprotein Increased expression associated with anaphylactic
degranulation
Knol et al., 1991
Anti-CD203c mAb mAb specific for an ecto-nucleotide
pyrophosphatase/phosphodiesterase
Constitutively expressed at low levels by human basophils,
its upregulation may be associated with piecemeal
degranulation
Bu¨hring et al.,
2004
Mouse basophils
Anti-mMCP8 mAb mAb specific for mouse mast cell protease 8
(mMCP8), which is a basophil-specific marker
Can be used to verify the identity of mouse basophils and
detect them in histological sections
Ugajin et al., 2009
MAR-1 mAb specific for FceRIa Transient depletion of basophils after injection, activation
and/or depletion of other cell subsets (e.g., mast cells and
FceRIþ dendritic cells)
Sokol et al., 2008
Ba103 mAb specific for CD200R3 Transient depletion of basophils after injection, activation
and/or depletion of other cell subsets (e.g., mast cells)
Obata et al., 2007
Basoph8 Mouse strain in which Mcpt8 was replaced by
IRES-YFP-Cre cassette
Constitutive deletion of basophils (490%) after crossing
to R-DTA mice
Sullivan et al.,
2011
Mcpt8-Cre BAC-transgenic mice that express Cre under the
control of Mcpt8
Constitutive deletion of basophils (490%) Ohnmacht et al.,
2010
Bas-TRECK Mice expressing human DTR under the control of
30 UTR element in the Il4 gene locus
Inducible basophil depletion (490%) after diphtheria
toxin injection
Sawaguchi et al.,
2012
Mcpt8DTR Mice expressing human DTR inserted in the
30 UTR of Mcpt8
Inducible basophil depletion (490%) after diphtheria
toxin injection
Wada et al., 2010
Abbreviations: BAC, bacterial artificial chromosome; DTR, diphtheria toxin receptor; IRES, internal ribosome entry site; mAb, monoclonal antibody; R-DTA,
ROSA-diphtheria toxin alpha; UTR, untranslated region; YFP, yellow fluorescent protein.
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to IgE-CAI. Adoptive transfer of different cell subsets isolated
from the bone marrow of wild-type mice into FceRI-
deficient mice suggested that basophils, although repre-
senting only E2% of the inflammatory cell infiltrate
within the skin lesions, were responsible for the development
of IgE-CAI. The critical role of basophils in IgE-CAI has
been confirmed using the basophil-depleting antibody Ba103
(Obata et al., 2007) and mouse models of basophil deficiency
(Ohnmacht et al., 2010; Sawaguchi et al., 2012; Egawa et al.,
2013).
Evidence suggests that basophils can also have an
immunoregulatory role in the skin. Basophil-derived IL-4
polarizes Ly-6CþCCR2þ monocytes recruited to the skin
after antigen challenge to an anti-inflammatory M2-like
phenotype (Egawa et al., 2013). Reduced Ly-6CþCCR2þ
monocyte recruitment in CCR2-deficient mice led to
exacerbation of IgE-CAI that was dampened by adoptive
transfer of Ly-6CþCCR2þ monocytes. How Ly-6CþCCR2þ
monocytes polarized by basophil-derived IL-4 modulate
IgE-CAI is unknown, although increased endocytic activity
and antigen clearance may be implicated in this process.
Interestingly, basophils mediate the anti-inflammatory effects
of intravenous immunoglobulin by inducing the inhibitory Fc
receptor FcgRIIB on macrophages via IL-4 (Anthony et al.,
2011). Collectively, these findings suggest that basophils can
exert previously unappreciated anti-inflammatory functions
that need to be fully elucidated to harness their therapeutic
potential.
Table 2. Involvement of basophils in human and mouse models of skin diseases
References
Human skin diseases
CIU Basophils have been observed in skin lesions of CIU. Basopenia is
a common feature of CIU and is inversely correlated with urticaria
severity. CIU patients can be classified as ‘‘responders’’ or
‘‘non-responders’’ (respectively CIU-R and CIU-NR) on the basis
of histamine release in response to anti-IgE-mediated activation of
basophils. Basopenia and suppressed CIU basophil anti-IgE-
mediated histamine release improve in spontaneous remission
and in response to therapy
Ying et al., 2002; Saini, 2009; Grattan
et al., 2003; Kern and Lichtenstein,
1976; Eckman et al., 2008; Gober
et al., 2008
AD Marked basophil infiltration has been observed in patch-tested sites
for house-dust mite allergen in sensitized AD patients. Basophils
infiltrate chronic skin lesions of approximately 60% of AD patients
Mitchell et al., 1982; Ito et al., 2011
ACD Basophils infiltrate skin lesions of some patients with ACD Dvorak and Mihm, 1972
Lepromatous leprosy, bullous pemphigoid,
scabies, insect bites (Cimex lectularius),
Henoch-Scho¨nlein purpura, eosinophilic
pustular folliculitis
Basophil infiltration (often together with eosinophil infiltration) has
been detected in lesions of these human skin disorders. However,
basophil density and the ratio of tissue basophils/eosinophils can
be variable. The specific contribution of human basophils to the
pathophysiology of these conditions remains to be established
Ito et al., 2011; Otsuka et al., 2013b;
Nakahigashi et al., 2013
SLE Basophils have been implicated in the development and progression
of lupus-like nephritis in Lyn / mice. However, basophils have
not been detected in SLE skin lesions, and their involvement in
SLE pathogenesis is still debated
Charles et al., 2010; Ito et al., 2011;
Dijkstra et al., 2012
HIV infection Several HIV products can modulate human basophil functions
in vitro. Patients with AIDS have HIV-1-infected basophil/mast
cell precursors in their peripheral blood
Marone et al., 2001; Li et al., 2001
Mouse models of skin diseases
IgE-CAI Basophils have a fundamental role as initiator cells of IgE-CAI.
Furthermore, they can promote the resolution of IgE-CAI through
the induction of alternative activation of monocytes/macrophages
Mukai et al., 2005; Obata et al.,
2007; Egawa et al., 2013; Ohnmacht
et al., 2010; Sawaguchi et al., 2012
Hapten-induced skin inflammation Basophil depletion in DT-treated Bas-TRECK mice led to a reduced
hapten-induced skin Th2-type response
Otsuka et al., 2013a
Acquired anti-tick immunity Basophils infiltrate the skin surrounding tick mouthparts during the
second tick infestation. Basophils have a fundamental role in the
development of tick-acquired resistance
Wada et al., 2010
TSLP-dependent atopic dermatitis Basophils infiltrate skin lesions in a TLSP-dependent mouse model
of AD. The contribution of basophils to the pathophysiology of this
model remains to be established
Li et al., 2006; Li et al., 2009;
Leyva-Castillo et al., 2013;
Siracusa et al., 2011
Abbreviations: ACD, allergic contact dermatitis; AD, atopic dermatitis; CIU, chronic idiopathic urticaria; DT, diphtheria toxin; IgE-CAI, IgE–mediated chronic
allergic inflammation; SLE, systemic lupus erythematosus; TSLP, thymic stromal lymphopoietin.
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Basophils are pivotal in inducing a Th2-type cutaneous
inflammation in response to hapten challenge (Otsuka et al.,
2013a). Basophil depletion in DT-treated Bas-TRECK mice led
to a reduced Th2-type response, as assessed by ear swelling
responses 1 and 6 hours after the last hapten application. By
contrast, cutaneous patch immunization with OVA induced a
basophil-independent Th2-type response, as assessed by
erythema, edema, erosion, and scaling.
In a mouse model of TSLP-dependent atopic dermatitis (AD)
induced by topical treatment with the vitamin D analog
MC903 (Li et al., 2006, 2009; Leyva-Castillo et al., 2013),
basophils were recruited to the skin in an IL-3-independent,
TSLP-dependent manner (Siracusa et al., 2011). The contribu-
tion of TSLP-elicited basophils to the pathophysiology of
MC903-induced AD remains to be defined.
Basophils are also involved in infectious diseases of the
skin. Tick infestations induce a Th2-type response associated
with the development of acquired resistance to tick feeding
(Wikel, 1996). The mechanisms underlying acquired tick
resistance are still poorly defined. Guinea pigs develop tick
resistance in parallel with accumulation of basophils and
eosinophils at tick feeding sites (Allen, 1973). Basophil deple-
tion, obtained with rabbit anti-guinea pig basophil serum,
eliminates tick resistance (Brown et al., 1982). These results
were challenged by evidence that mast cell–deficient mice
fail to develop tick resistance while apparently showing no
basophil infiltration at tick feeding sites (Matsuda et al., 1985;
Steeves and Allen, 1991). However, when the anti-mMCP-8
monoclonal antibody was used, clusters of basophils appeared
around the tick mouthparts during the second (but not the
first) infestation. Tick-acquired resistance was abolished in
Mcpt8DTR mice when basophils were depleted with Ba103
or MAR-1 treatment or DT administration before the second
infestation. Interestingly, the development of tick resistance
also required antibodies and the expression of their receptors
on basophils (Wada et al., 2010). Additional studies are
needed to fully appreciate the relative contribution of
basophils and mast cells to acquired tick resistance.
BASOPHILS IN HUMAN SKIN DISORDERS
Basophils infiltrate skin lesions in human skin disorders such
as chronic idiopathic urticaria (CIU) (Ying et al., 2002; Ito
et al., 2011), allergic contact dermatitis (Dvorak and Mihm,
1972), and AD (Ito et al., 2011) (see Table 2). Basophil infil-
tration in the skin is often accompanied by eosinophil
infiltration, although basophil density and the ratio of tissue
basophils/eosinophils can vary.
Mediator release from mast cells and basophils is pivotal in
CIU pathogenesis (Cohen and Rosenstreich, 1986; Jacques
et al., 1992; Smith et al., 1995). Circulating IgG autoanti-
bodies against IgE or FceRIa occur in E40% of CIU patients
(Gruber et al., 1988; Hide et al., 1993). Several observations
indicate that basophils have a relevant pathogenetic role
in CIU (Saini, 2009). Blood basopenia is frequent in CIU
possibly owing to basophil recruitment to the skin. Notably,
the number of circulating basophils is inversely correlated to
the severity of urticaria (Grattan et al., 2003). As early as 1976,
Lichtenstein and collaborators demonstrated that IgE-mediated
basophil histamine release is reduced in CIU patients (Kern
and Lichtenstein, 1976). This seminal observation was con-
firmed and extended with the finding that CIU patients can be
classified responders (CIU-R) or nonresponders (CIU-NR) on
the basis of basophil histamine release in response to anti-IgE
(410% or o10% of cellular histamine content, respectively).
There is evidence that the pattern of basophil IgE-mediated
histamine release observed in these patients results from
altered FceRI-mediated signaling (Vonakis et al., 2007;
Vonakis and Saini, 2008; Saini, 2009). Basopenia and suppres-
sed anti-IgE-mediated histamine release in basophils of CIU
patients improve in natural remission or in response to clinical
therapy (e.g., corticosteroid or omalizumab (an anti-IgE
humanized monoclonal antibody)), independently of autoanti-
bodies (Grattan et al., 2003; Eckman et al., 2008; Gober et al.,
2008). Interestingly, omalizumab, which is highly effective in
CIU (Maurer et al., 2013), rapidly reduces free IgE levels and
basophil and skin mast cell FceRI expression (Beck et al.,
2004). Decrease in FceRI expression is faster on basophils than
mast cells. Thus, basophils are more likely to account for the
rapid effects of omalizumab observed in CIU treatment.
Marked basophil infiltration has been observed in patch-
tested sites for house-dust mite allergen in sensitized AD
patients (Mitchell et al., 1982; Ito et al., 2011). Basophils infil-
trate chronic skin lesions of approximately 60% of AD
patients, albeit at a low cell density (Ito et al., 2011). The
reasons for these apparent discrepancies are not completely
understood. It is possible that chronic skin lesions of AD
patients are characterized by a more prevalent Th1 milieu
and, thus, a sparse basophil infiltrate (Werfel, 2009). Basophils
could participate in the different stages of AD by producing
angiogenic (VEGF-A and Ang1) (de Paulis et al., 2006; Prevete
et al., 2013) and tissue remodeling factors (amphiregulin)
(Qi et al., 2010). Moreover, protein A of Staphylococcus
aureus, a common cause of skin infections in patients with AD
(Kuo et al., 2013), is a potent activator of human basophils,
thereby acting as an immunoglobulin superantigen (Marone
et al., 1982, 1985, 1987). Finally, IL-33 and its receptor ST2
are increased in skin lesions of AD patients, and their levels
are further increased by allergens and bacterial toxins (Savinko
et al., 2012). IL-33 modulates cytokine production and
induces CD11b expression on human basophils and thus
can enhance their transmigration into inflamed skin
(Suzukawa et al., 2008; Pecaric-Petkovic et al., 2009).
Basophil skin infiltrates have been observed in other
cutaneous diseases such as lepromatous leprosy, bullous
pemphigoid, eosinophilic pustular folliculitis, and Henoch-
Scho¨nlein purpura (Ito et al., 2011; Otsuka et al., 2013b).
Interestingly, although mouse basophils appear to cluster
around tick mouthparts during the secondary tick infestation
(Wada et al., 2010), there is no clear-cut evidence of basophil
infiltration in the skin of tick-infested patients (Ito et al., 2011;
Nakahigashi et al., 2013). Cimex lectularius bites and scabies
lesions show basophil infiltration (Ito et al., 2011).
Skin and mucosal tissue disorders are common during HIV
infection (Tschachler et al., 1996), and several HIV products
can modulate basophil functions (Marone et al., 2001). gp120
interacts with the VH3 domain of IgE to induce the release of
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histamine, LTC4, IL-4, and IL-13 from human basophils (Florio
et al., 2000; Patella et al., 2000). Tat (de Paulis et al., 2000),
gp41 (de Paulis et al., 2002), and Nef (de Paulis et al.,
unpublished data) induce human basophil chemotaxis by
interacting with CCR3, FPR2, and CXCR4 (C-X-C motif
chemokine receptor 4), respectively. Moreover, a population
of basophil/mast cell precursors in peripheral blood of allergic
donors can be infected in vitro by HIV-1, and patients with
AIDS have HIV-1-infected basophil/mast cell precursors in
their peripheral blood (Li et al., 2001). However, the roles of
basophils in the development of HIV-related skin disorders
have yet to be established in vivo.
Systemic lupus erythematosus (SLE) is a systemic autoim-
mune disorder characterized by early skin involvement and
end-stage renal disease. It has been reported that peripheral
blood basophils from Lyn / mice can be activated by
IgE-containing immune complexes (IgE-IC) (Charles et al.,
2010). In this model, basophils migrate to lymph nodes and
spleen, and activate B cells, thereby enhancing the production
of self-reactive IgE that causes lupus-like nephritis (Charles
et al., 2010). However, human basophils have not been
detected in SLE skin lesions (Ito et al., 2011), and their
involvement in SLE pathogenesis is controversial (Dijkstra
et al., 2012).
OPEN ISSUES AND PERSPECTIVES
During recent years, basophil biology has undergone an
impressive renaissance owing to multiple mouse models of
basophil deficiency; however, several questions remain open.
It is still only partially known how basophils, notwithstanding
their small number, can exert such a strong effect on the
pathogenesis of skin disorders, as discovered in mouse
models. Another issue concerns the anti-inflammatory effect
found in some experimental conditions (Anthony et al., 2011;
Egawa et al., 2013). In vitro and in vivo studies are required to
elucidate the outcome of the interaction among basophils,
skin-resident cells, and other innate and adaptive immune
cells. Indeed, basophil-derived cytokines (e.g., IL-3, IL-4,
IL-13, VEGF-A, etc.), T cell– and mast cell–derived IL-3, and
epithelium- and/or stroma-derived cytokines (e.g., TSLP, IL-33,
etc.) may cooperate to shape the proinflammatory versus anti-
inflammatory functions of monocytes, macrophages, and DCs
(Barleon et al., 1996; Heil et al., 2000; Soumelis et al., 2002;
Cockerill, 2004; de Paulis et al., 2006; Liu et al., 2007;
Skin
TSLP
IL-33
TSLP
IL-4
Basophil IL-4
IL-3 T cell
Mast cell
TSLP
Blood vessel
Skin-draining
lymph node
DC
DC
B-cell zone
AA macrophage
Naive T cell
Basophil
Th2 cellT-cell zone
IL-13
VEGF-A
Monocyte
Antigen Superantigen
Figure 1. Hypothetical mechanisms by which basophils promote and/or dampen skin inflammation. Antigens or superantigens induce IgE–mediated basophil
activation that leads to the production of several cytokines (e.g., IL-4, IL-13, vascular endothelial growth factor A (VEGF-A), IL-3). Basophil activation can be
enhanced by the tissue-derived cytokine IL-33, and by T-cell- and mast cell–derived IL-3. Thymic stromal lymphopoietin (TSLP), expressed by keratinocytes
in inflammatory conditions, promotes the maturation of a population of mouse basophils different from IL-3-elicited basophils. However, there is no evidence
that TSLP activates human basophils, as suggested by the dashed line. Basophil-derived IL-4 and IL-13 polarize monocytes/macrophages to an alternative
activation state that can be involved in both promoting and dampening the inflammatory response. Furthermore, basophils release VEGF-A, which is chemotactic
for monocytes. TSLP, acting alone or in cooperation with IL-4, promotes alternative activation (AA) of monocytes/macrophages and fosters the maturation
of dendritic cells (DCs) toward T helper type 2 (Th2)-inducing DCs. In some experimental conditions, basophils migrate to lymph nodes and may therefore
contribute to triggering Th2 responses.
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Suzukawa et al., 2008; Pecaric-Petkovic et al., 2009;
Schroeder et al., 2009; Anthony et al., 2011; Siracusa et al.,
2011; Cook et al., 2012; Bell et al., 2013; Egawa et al., 2013;
Han et al., 2013; Ziegler et al., 2013) (Figure 1). Finally, a
critical challenge is to translate the relevance of mouse models
to human skin diseases, taking into account the inherent
differences between human and mouse basophils.
In conclusion, more than 130 years after its discovery, the
enigmatic role of the basophil is being progressively unraveled
owing to mouse models of basophil depletion, new techni-
ques to obtain highly purified basophil preparations, and
monoclonal antibodies that specifically detect mouse and
human basophils in tissues. Novel and convincing evidence
gathered by this new wave of research indicates how these
immune cells, notwithstanding their scarcity, have a role in
host defense against skin parasites and in skin allergic and
autoimmune disorders.
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